The Role of PI3K inhibitors in NHL
The Role of PI3K inhibitors in NHL
Dr. Tycel J. Phillips discusses the Role of PI3K inhibitors in Non-Hodgkin’s Lymphoma Dr. Tycel J. Phillips discusses the Role of PI3K inhibitors in Non-Hodgkin’s LymphomaAssoc. Prof. Tycel Phillips
Watch the video and download the slidesAssoc. Prof. Tycel Phillips
Haematologist-Oncologist
University of Michigan Rogel Cancer Center
United States (US)
Dr. Tycel Phillips, is a lymphoma specialist with a research and clinical focus on non-hodgkin lymphoma. Dr. Phillips completed his hematology-oncology fellowship at University Hospitals/Case Western University. While at Case Western, Dr. Phillips began to focus on the development of clinical trials utilizing novel agents in lymphoma. He has continued his focus on clinical research upon his appointment at the University of Michigan and in addition has been the site primary investigator on numerous clinical trials in multiple subtypes of lymphoma. Dr. Phillips’s research interests include evaluation of resistance mechanisms in mantle cell lymphoma (MCL), non-cytotoxic chemotherapeutic treatment in frontline MCL, and other novel combinations in relapsed/refractory lymphoma. Dr. Phillips is involved in professional societies including the American Society of Clinical Oncology (ASCO) and American Society of Hematology (ASH).
Assoc. Prof. Tycel Phillips has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
| 5 min | 2019
This programme was made for you: your opinion matters
Share your feedback in just 4 clicks and help us to continue to create the content you need.
I agree that this educational programme:
Was valuable to me:
1/4
Has improved my knowledge of this topic:
2/4
Is likely to change my clinical practice:
3/4
Was balanced and unbiased:
4/4
download resources
This programme was made for you: your opinion matters
Share your feedback in just 4 clicks and help us to continue to create the content you need.
I agree that this educational programme:
Was valuable to me:
1/4
Has improved my knowledge of this topic:
2/4
Is likely to change my clinical practice:
3/4
Was balanced and unbiased:
4/4
LYMPHOMA & MYELOMA CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from Bayer and from Karyopharm Therapeutics.
Other programmes of interest
Other programmes developed by Assoc. Prof. Tycel Phillips
Assoc. Prof. Tycel Phillips
Haematologist-Oncologist
University of Michigan Rogel Cancer Center
United States (US)